Brian Strem
Algemeen Directeur bij KIORA PHARMACEUTICALS, INC.
Vermogen: 49 488 $ op 30-04-2024
Actieve functies van Brian Strem
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Algemeen Directeur | 26-07-2021 | - |
| Directeur/Bestuurslid | 26-07-2021 | - | |
| President | 26-07-2021 | - | |
| Comptroller/Controller/Auditor | 16-06-2022 | - | |
| Financieel Directeur/CFO | 16-06-2022 | - | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Directeur/Bestuurslid | 01-06-2015 | - |
| Financieel Directeur/CFO | - | - | |
| Oprichter | - | - | |
| Bedrijfssecretaris | - | - | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Directeur/Bestuurslid | 01-01-2020 | - |
| Oprichter | 01-01-2020 | - | |
| Corporate Officer/Principal | - | - | |
| Bayon Therapeutics, Inc. | Directeur/Bestuurslid | - | - |
| Oprichter | - | - |
Loopbaan van Brian Strem
Opleiding van Brian Strem
| Cornell University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director/Board Member | 4 |
| Founder | 3 |
| Director of Finance/CFO | 2 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
Yellowbrick Bio LLC
Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Health Technology |
| Bayon Therapeutics, Inc. |
- Beurs
- Insiders
- Brian Strem
- Ervaring
